In these studies, we took advantage of the fact that NOD2 cross-regulation can be assessed by intra-peritoneal administration of exogenous MDP so as to cause enhanced NOD2 stimulation and thus inhibition of experimental colitis, such as DSS-colitis or TNBS-colitis (21). Here, NOD2 is linked to colitis.